NEOG - Neogen Corp Stock Price, Fair Value and News

12.33USD-0.09 (-0.72%)Market Closed

Market Summary

USD12.33-0.09

Market Closed

-0.72%

NEOG Alerts

4 major insider buys recently.

Big fall in earnings (Y/Y)
Losses in recent quarter

NEOG Stock Price

View Fullscreen

NEOG RSI Chart

NEOG Valuation

Market Cap

2.7B

Price/Earnings (Trailing)

1.7K

Price/Sales (Trailing)

2.87

EV/EBITDA

29.28

Price/Free Cashflow

26.85

NEOG Price/Sales (Trailing)

NEOG Profitability

Operating Margin

78.03%

EBT Margin

-0.03%

Return on Equity

0.05%

Return on Assets

0.03%

Free Cashflow Yield

3.72%

NEOG Fundamentals

NEOG Revenue

Revenue (TTM)

929.2M

Rev. Growth (Yr)

4.84%

Rev. Growth (Qtr)

-0.36%

NEOG Earnings

Earnings (TTM)

1.6M

Earnings Growth (Yr)

-124.69%

Earnings Growth (Qtr)

42.01%

Breaking Down NEOG Revenue

Last 7 days

0.2%

Last 30 days

-21.9%

Last 90 days

-20.4%

Trailing 12 Months

-28.7%

How does NEOG drawdown profile look like?

NEOG Financial Health

Current Ratio

3.82

Debt/Equity

0.28

Debt/Cashflow

0.11

NEOG Investor Care

Shares Dilution (1Y)

0.18%

Diluted EPS (TTM)

-0.01

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	929.2M	0	0	0
2023	720.7M	822.4M	919.1M	918.7M
2022	514.5M	527.2M	531.2M	630.7M
2021	450.1M	468.5M	487.4M	503.0M
2020	418.9M	418.2M	426.1M	433.3M
2019	412.5M	414.2M	416.0M	416.7M
2018	388.7M	397.9M	403.3M	409.7M
2017	352.8M	361.6M	372.2M	382.1M
2016	309.8M	321.3M	330.1M	341.2M
2015	271.7M	283.1M	290.3M	301.5M
2014	236.2M	247.4M	256.5M	265.3M
2013	200.1M	207.5M	216.3M	225.2M
2012	179.1M	184.0M	188.1M	193.9M
2011	164.6M	172.7M	175.5M	176.4M
2010	0	140.5M	148.6M	156.6M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Neogen Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 25, 2024	jones douglas edward	sold (taxes)	-3,480	11.96	-291	chief operating officer
Apr 25, 2024	rocklin amy m	acquired	6,733	11.96	563	chief legal officer
Apr 25, 2024	adent john edward	acquired	25,271	11.96	2,113	ceo
Apr 25, 2024	jones douglas edward	acquired	10,106	11.96	845	chief operating officer
Apr 25, 2024	adent john edward	sold (taxes)	-7,355	11.96	-615	ceo
Apr 23, 2024	adent john edward	acquired	211,297	12.09	17,477	ceo
Apr 17, 2024	jones douglas edward	bought	123,590	12.359	10,000	chief operating officer
Apr 11, 2024	borel james c	bought	97,986	13.0648	7,500	-
Apr 10, 2024	adent john edward	bought	284,190	12.3561	23,000	ceo
Apr 10, 2024	naemura david h.	bought	156,321	12.5057	12,500	cfo

Which funds bought or sold NEOG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 29, 2024	PRINCIPAL FINANCIAL GROUP INC	added	5.14	-2,878,640	13,570,900	0.01%
Apr 29, 2024	HAZLETT, BURT & WATSON, INC.	reduced	-8.36	-5,000	18,000	0.01%
Apr 29, 2024	COMMONWEALTH EQUITY SERVICES, LLC	reduced	-2.72	-174,000	559,000	-%
Apr 29, 2024	GREENLEAF TRUST	reduced	-4.36	-57,499	172,901	-%
Apr 26, 2024	RIVERBRIDGE PARTNERS LLC	reduced	-1.81	-10,075,000	33,824,700	0.41%
Apr 26, 2024	SYSTM Wealth Solutions LLC	unchanged	-	-3,274	11,930	-%
Apr 26, 2024	Planning Capital Management Corp	unchanged	-	-2,320	8,459	0.01%
Apr 26, 2024	PEREGRINE CAPITAL MANAGEMENT LLC	new	-	8,904,650	8,904,650	0.26%
Apr 26, 2024	YHB Investment Advisors, Inc.	new	-	20,372	20,372	-%
Apr 26, 2024	UMB Bank, n.a.	new	-	915	915	-%

Are Funds Buying or Selling NEOG?

Are funds buying NEOG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NEOG

No. of Funds

Unveiling Neogen Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.04%	19,546,737	SC 13G/A
Feb 09, 2024	wasatch advisors lp	-	0	SC 13G/A
Jan 30, 2024	norges bank	8.41%	18,189,674	SC 13G/A
Jan 24, 2024	blackrock inc.	11.5%	24,851,419	SC 13G/A
Feb 14, 2023	susquehanna securities, llc	3.8%	8,291,607	SC 13G/A
Feb 14, 2023	norges bank	8.52%	18,422,570	SC 13G/A
Feb 09, 2023	vanguard group inc	8.82%	19,057,576	SC 13G/A
Feb 08, 2023	wasatch advisors inc	-	0	SC 13G/A
Jan 23, 2023	blackrock inc.	11.3%	24,460,988	SC 13G/A
Oct 11, 2022	brown capital management llc	4.04%	8,739,338	SC 13G/A

Recent SEC filings of Neogen Corp

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading
Apr 26, 2024	4	Insider Trading
Apr 24, 2024	4	Insider Trading
Apr 17, 2024	3	Insider Trading
Apr 17, 2024	4	Insider Trading
Apr 11, 2024	4	Insider Trading
Apr 10, 2024	4	Insider Trading
Apr 10, 2024	4	Insider Trading
Apr 09, 2024	10-Q	Quarterly Report

Peers (Alternatives to Neogen Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
DHR	182.7B	23.7B	-1.24%	2.02%	41.5	7.7	-8.94%	-35.72%
IDXX	40.9B	3.7B	-8.74%	0.65%	48.45	11.18	8.72%	24.44%
A	40.2B	6.7B	-5.82%	0.71%	32.49	5.96	-2.81%	-6.58%
DGX	15.4B	9.3B	3.81%	-0.93%	18.14	1.65	-3.29%	6.68%
MEDP	12.0B	2.0B	-3.91%	88.07%	38.5	6.13	25.57%	21.62%
CRL	11.8B	4.1B	-15.48%	20.46%	24.78	2.85	3.86%	-2.39%
NTRA	11.2B	1.1B	1.55%	76.98%	-25.8	10.36	31.99%	20.63%
EXAS	10.8B	2.5B	-14.06%	-6.40%	-52.77	4.31	19.93%	67.26%
MID-CAP
NEOG	2.7B	929.2M	-21.86%	-28.69%	1.7K	2.87	28.93%	111.61%
GH	2.2B	563.9M	-12.75%	-20.04%	-4.57	3.88	25.45%	26.76%
SMALL-CAP
CDNA	401.8M	280.3M	-26.72%	-6.51%	-2.11	1.43	-12.89%	-148.37%
ACRS	85.8M	31.2M	-2.42%	-86.92%	-0.97	2.75	5.03%	-1.81%
APDN	67.9M	9.0M	875.61%	304.04%	-9.4	7.55	-53.31%	2.21%
AWH	39.7M	9.2M	3.87%	-30.75%	-2.38	4.34	11.85%	44.12%
BIOC	183.8K	25.9M	-50.00%	-94.83%	-0.01	0.01	-57.78%	-93.11%

Neogen Corp News

Latest updates

Neogen Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-0.4%	229	230	229	242	218	230	132	140	128	131	128	127	117	115	109	109	100	108	101	110	98.00
Gross Profit	0.1%	117	117	117	123	108	113	62.00	65.00	57.00	61.00	60.00	58.00	54.00	53.00	50.00	52.00	45.00	51.00	48.00	51.00	45.00
Operating Expenses	2.5%	105	102	98.00	100	92.00	120	56.00	47.00	51.00	48.00	38.00	37.00	38.00	34.00	31.00	32.00	32.00	33.00	32.00	32.00	30.00
S&GA Expenses	6.9%	48.00	45.00	46.00	43.00	39.00	36.00	23.00	21.00	21.00	21.00	21.00	21.00	19.00	18.00	17.00	16.00	18.00	18.00	18.00	18.00	17.00
R&D Expenses	-15.7%	5.00	6.00	7.00	7.00	7.00	7.00	5.00	4.00	5.00	4.00	4.00	4.00	4.00	4.00	4.00	3.00	4.00	4.00	4.00	4.00	3.00
EBITDA Margin	-2.3%	0.12*	0.13*	0.14*	0.13*	0.08*	0.07*	0.13*	0.16*	0.17*	0.19*	0.20*	0.21*	-	-	-	-	-	-	-	-	-
Income Taxes	-1361.5%	-3.80	-0.26	0.00	2.00	-10.50	8.00	1.00	4.00	1.00	2.00	5.00	4.00	3.00	3.00	4.00	5.00	2.00	3.00	3.00	4.00	4.00
Earnings Before Taxes	-55.4%	-5.82	-3.75	2.00	8.00	-2.26	-34.09	7.00	19.00	7.00	13.00	22.00	20.00	16.00	19.00	20.00	21.00	14.00	19.00	18.00	19.00	17.00
EBT Margin	-107.6%	0.00*	0.00*	-0.03*	-0.03*	-0.01*	0.00*	0.08*	0.11*	0.12*	0.14*	0.16*	0.16*	0.17*	0.17*	0.17*	0.17*	0.17*	0.18*	0.18*	-	-
Net Income	42.0%	-2.02	-3.49	2.00	6.00	8.00	-41.84	5.00	15.00	5.00	11.00	17.00	16.00	13.00	16.00	16.00	16.00	12.00	16.00	15.00	16.00	13.00
Net Income Margin	-86.9%	0.00*	0.01*	-0.03*	-0.03*	-0.02*	-0.03*	0.07*	0.09*	0.10*	0.11*	0.13*	0.13*	0.14*	0.14*	0.14*	0.14*	0.14*	0.14*	0.14*	-	-
Free Cashflow	-292.2%	-30.21	16.00	23.00	91.00	-17.07	-18.73	-14.14	20.00	7.00	18.00	23.00	22.00	12.00	22.00	25.00	26.00	20.00	17.00	24.00	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.4%	4,582	4,602	4,561	4,554	4,561	4,563	977	993	981	968	932	920	880	846	822	797	774	751	721	696	673
Current Assets	-3.5%	602	624	584	586	555	643	608	627	610	611	609	591	555	578	557	537	515	500	474	450	423
Cash Equivalents	-21.5%	161	206	179	163	67.00	100	107	44.00	43.00	51.00	71.00	76.00	73.00	114	61.00	66.00	51.00	66.00	56.00	42.00	94.00
Inventory	13.6%	182	161	141	134	144	136	129	122	113	107	102	101	99.00	93.00	98.00	95.00	89.00	86.00	88.00	86.00	85.00
Net PPE	11.5%	272	244	221	199	165	148	121	111	105	101	100	100	98.00	84.00	81.00	79.00	78.00	77.00	75.00	75.00	76.00
Goodwill	-0.1%	2,136	2,138	2,138	2,137	2,135	2,122	1,975	143	150	143	130	131	133	112	112	110	110	104	103	104	104
Liabilities	-1.3%	1,436	1,455	1,415	1,420	1,383	1,457	94.00	106	106	101	77.00	80.00	73.00	68.00	70.00	72.00	62.00	60.00	61.00	58.00	53.00
Current Liabilities	-10.6%	158	177	138	145	107	153	67.00	78.00	66.00	63.00	51.00	54.00	46.00	45.00	46.00	48.00	39.00	39.00	40.00	38.00	34.00
Long Term Debt	0.1%	888	887	886	885	885	924	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	887	886	885	885	924	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	0.0%	3,146	3,148	3,146	3,134	3,126	3,106	884	887	876	865	855	840	808	777	752	725	712	691	660	638	620
Retained Earnings	-0.4%	561	563	567	565	559	551	593	588	573	568	557	540	524	510	495	479	462	450	434	419	403
Additional Paid-In Capital	0.2%	2,580	2,575	2,572	2,568	2,565	2,561	313	310	308	305	298	295	290	273	264	249	255	244	232	222	217
Accumulated Depreciation	-	-	-	-	120	-	-	-	105	-	-	-	98.00	-	-	-	75.00	-	-	-	66.00	-
Shares Outstanding	0.0%	217	217	216	216	216	216	108	108	108	108	107	106	107	106	106	105	106	105	105	-	-
Float	-	-	-	-	-	-	3,572	-	-	-	4,325	-	-	-	3,952	-	-	-	3,489	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-292.2%	-30,206	15,714	23,009	90,966	-17,069	-18,726	-14,143	20,390	6,591	17,847	23,210	21,969	11,596	22,390	25,134	25,628	19,778	16,753	23,719	20,877	10,382
Share Based Compensation	4.8%	3,679	3,512	2,638	2,866	2,812	2,632	1,867	2,109	1,607	1,748	1,690	1,664	1,581	1,511	1,681	1,673	1,640	1,612	1,543	1,406	1,306
Cashflow From Investing	-226.9%	-14,638	11,536	-8,684	6,876	19,523	93,002	81,638	-17,099	-15,386	-39,337	-25,407	-31,710	-60,918	22,796	-35,732	-12,208	-42,951	-18,265	-15,361	-75,515	-20,361
Cashflow From Financing	502.3%	1,247	-310	1,062	252	-39,977	-79,261	905	-1,029	1,223	5,571	1,048	10,743	10,143	7,563	5,095	1,490	8,702	10,505	8,708	3,282	349

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NEOG Income Statement

2024-02-29

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Revenues
Total revenue	$ 228,812	$ 218,255	$ 687,428	$ 580,637
Cost of Revenues
Total Cost of Revenues	111,929	110,291	337,010	297,864
Gross Profit	116,883	107,964	350,418	282,773
Operating Expenses
Sales and marketing	47,920	38,598	138,535	98,329
General and administrative	52,087	46,424	148,929	151,369
Research and development	4,853	7,258	17,331	18,985
Total Operating Expenses	104,860	92,280	304,795	268,683
Operating Income	12,023	15,684	45,623	14,090
Other Expense
Interest income	1,612	640	5,265	2,163
Interest expense	(18,285)	(17,460)	(54,773)	(38,007)
Other expense	(1,172)	(1,124)	(4,021)	(7,938)
Total Other Expense	(17,845)	(17,944)	(53,529)	(43,782)
Loss Before Taxes	(5,822)	(2,260)	(7,906)	(29,692)
Provision for Income Taxes	(3,800)	(10,450)	(3,900)	(1,250)
Net (Loss) Income	$ (2,022)	$ 8,190	$ (4,006)	$ (28,442)
Net (Loss) Earnings Per Share
Basic	$ (0.01)	$ 0.04	$ (0.02)	$ (0.16)
Diluted	$ (0.01)	$ 0.04	$ (0.02)	$ (0.16)
Weighted Average Shares Outstanding
Basic	216,597,777	216,217,702	216,438,643	179,666,118
Diluted	216,597,777	216,399,003	216,438,643	179,666,118
Product Revenues
Revenues
Total revenue	$ 202,178	$ 190,688	$ 610,448	$ 500,797
Cost of Revenues
Total Cost of Revenues	98,144	94,377	293,456	252,348
Service Revenues
Revenues
Total revenue	26,634	27,567	76,980	79,840
Cost of Revenues
Total Cost of Revenues	$ 13,785	$ 15,914	$ 43,554	$ 45,516

NEOG Balance Sheet

2024-02-29

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Feb. 29, 2024	May 31, 2023
Current Assets
Cash and cash equivalents	$ 161,437	$ 163,240
Marketable securities	7,010	82,329
Accounts receivable, net of allowance of $4,099 and $2,827	173,592	153,253
Inventories, net	182,390	133,812
Prepaid expenses and other current assets	78,042	53,297
Total Current Assets	602,471	585,931
Net Property and Equipment	272,282	198,749
Other Assets
Right of use assets	15,301	11,933
Goodwill	2,136,338	2,137,496
Intangible assets, net	1,539,744	1,605,103
Other non-current assets	16,356	15,220
Total Assets	4,582,492	4,554,432
Current Liabilities
Current portion of finance lease	2,521
Accounts payable	89,748	76,669
Accrued compensation	20,305	25,153
Income tax payable	11,573	6,951
Accrued interest	3,438	11,149
Deferred revenue	5,486	4,616
Other accruals	24,773	20,934
Total Current Liabilities	157,844	145,472
Deferred Income Tax Liability	353,853	353,427
Non-Current Debt	887,653	885,439
Other Non-Current Liabilities	36,968	35,877
Total Liabilities	1,436,318	1,420,215
Commitments and Contingencies (note 12)
Equity
Preferred stock, $1.00 par value, 100,000 shares authorized, none issued and outstanding	0	0
Common stock, $0.16 par value, 315,000,000 shares authorized, 216,607,746 and 216,245,501 shares issued and outstanding at February 29, 2024, and May 31, 2023, respectively	34,657	34,599
Additional paid-in capital	2,579,955	2,567,828
Accumulated other comprehensive loss	(29,473)	(33,251)
Retained earnings	561,035	565,041
Total Stockholders' Equity	3,146,174	3,134,217
Total Liabilities and Stockholders' Equity	$ 4,582,492	$ 4,554,432

About Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

CEO	Mr. John Edward Adent
WEBSITE	neogen.com
INDUSTRY	Diagnostics & Research
EMPLOYEES	2640

Neogen Corp Frequently Asked Questions

What is the ticker symbol for Neogen Corp? What does NEOG stand for in stocks?

NEOG is the stock ticker symbol of Neogen Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Neogen Corp (NEOG)?

As of Tue Apr 30 2024, market cap of Neogen Corp is 2.67 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NEOG stock?

You can check NEOG's fair value in chart for subscribers.

What is the fair value of NEOG stock?

You can check NEOG's fair value in chart for subscribers. The fair value of Neogen Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Neogen Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NEOG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Neogen Corp a good stock to buy?

The fair value guage provides a quick view whether NEOG is over valued or under valued. Whether Neogen Corp is cheap or expensive depends on the assumptions which impact Neogen Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NEOG.

What is Neogen Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, NEOG's PE ratio (Price to Earnings) is 1.71 Thousand and Price to Sales (PS) ratio is 2.87. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NEOG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Neogen Corp's stock?

In the past 10 years, Neogen Corp has provided -0.021 (multiply by 100 for percentage) rate of return.